Sage Journals: Discover world-class research

Abstract

Background

Postoperative glycemic control improves cardiac surgery outcomes but insulin protocols are limited by complexity and inflexibility. We sought to evaluate the effect of implementing an electronic glycemic management system (eGMS) in conjunction with a cardiac surgery endocrinology consult service on glycemic control and outcomes after cardiac surgery.

Methods

All patients with a calculated preoperative risk of mortality who underwent cardiac surgery before and after implementation of an eGMS and an endocrinology consult service were identified. Glycemic control and surgical outcomes were compared using univariate analysis, and multivariate regression was used to model the risk-adjusted effects of the interventions on glycemic control, surgical outcomes, and resource utilization. The health care–related value added by the interventions was calculated by dividing risk-adjusted outcomes by total hospital costs.

Results

A total of 2612 patients were identified, with 1263 patients in the preimplementation cohort and 1349 in the postimplementation cohort. Multivariate regression demonstrated fewer postoperative hyperglycemic events (odds ratio [OR] 0.8, 95% CI, 0.65-0.99) after protocol implementation without an increase in hypoglycemic events (OR 0.96, 95% CI, 0.71-1.3). Average day-weighted mean glucose decreased from 144 to 138 mg/dL (P < .001). The improved glycemic control correlated with a risk-adjusted decrease in composite morbidity or mortality (OR 0.61, 95% CI, 0.47-0.79). Although hospital costs increased after implementation, the protocol increased health care–related value by 38%.

Conclusion

Implementation of a protocol consisting of an eGMS paired with a cardiac surgery–specific endocrinology consult service was associated with improved glycemic control and reduced morbidity. Despite higher costs health care–related value increased as a result of eGMS implementation.

Keywords

cardiac surgery critical care electronic glycemic management systemx

Get full access to this article

View all access options for this article.

References

Furnary

AP.

. Clinical effects of hyperglycemia in the cardiac surgery population: the Portland diabetic project. Endocr Pract. 2006;12(Suppl 3):22-26.doi:10.4158/EP.12.S3.22

Jones

KW.

Cain

AS.

Mitchell

et al. Hyperglycemia predicts mortality after CABG: postoperative hyperglycemia predicts dramatic increases in mortality after coronary artery bypass graft surgery. J Diabetes Complications. 2008;22(6):365-370.doi:10.1016/j.jdiacomp.2007.05.006

Estrada

CA.

Young

JA.

Wiley Nifong

Chitwood

. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting. Ann Thorac Surg. 2003;75(5):1392-1399.doi:10.1016/S0003-4975(02)04997-4

Lazar

HL.

McDonnell

Chipkin

et al. The Society of thoracic surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87(2):663-669.doi:10.1016/j.athoracsur.2008.11.011

Zerr

KJ.

Furnary

AP.

Grunkemeier

GL.

Bookin

Kanhere

Starr

. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63(2):356-361.doi:10.1016/S0003-4975(96)01044-2

Carr

JM.

Sellke

FW.

Fey

et al. Implementing tight glucose control after coronary artery bypass surgery. Ann Thorac Surg. 2005;80(3):902-909.doi:10.1016/j.athoracsur.2005.03.105

van den Berghe

Wouters

Weekers

et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359-1367.doi:10.1056/NEJMoa011300

Blaha

Kopecky

Matias

et al. Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care. 2009;32(5):757-761.doi:10.2337/dc08-1851

Davidson

PC.

Steed

RD.

Bode

BW.

Hebblewhite

HR.

Prevosti

Cheekati

. Use of a computerized intravenous insulin algorithm within a nurse-directed protocol for patients undergoing cardiovascular surgery. J Diabetes Sci Technol. 2008;2(3):369-375.doi:10.1177/193229680800200305

10.

Thiessen

Vanhorebeek

Van den Berghe

. Glycemic control and outcome related to cardiopulmonary bypass. Best Pract Res Clin Anaesthesiol. 2015;29(2):177-187.doi:10.1016/j.bpa.2015.03.003

11.

Knapik

Nadziakiewicz

Urbanska

Saucha

Herdynska

Zembala

. Cardiopulmonary bypass increases postoperative glycemia and insulin consumption after coronary surgery. Ann Thorac Surg. 2009;87(6):1859-1865.doi:10.1016/j.athoracsur.2009.02.066

12.

Hermanides

Bosman

RJ.

Vriesendorp

et al. Hypoglycemia is associated with intensive care unit mortality. Crit Care Med. 2010;38(6):1430-1434.doi:10.1097/CCM.0b013e3181de562c

13.

Johnston

LE.

Kirby

JL.

Downs

et al. Postoperative hypoglycemia is associated with worse outcomes after cardiac operations. Ann Thorac Surg. 2017;103(2):526-532.doi:10.1016/j.athoracsur.2016.05.121

14.

Lazar

HL.

McDonnell

MM.

Chipkin

Fitzgerald

Bliss

Cabral

. Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Ann Surg. 2011;254(3):458-464.doi:10.1097/SLA.0b013e31822c5d78

15.

Davidson

PC.

Steed

RD.

Bode

. Glucommander: a computer-directed intravenous insulin system shown to be safe, simple, and effective in 120,618 H of operation. Diabetes Care. 2005;28(10):2418-2423.doi:10.2337/diacare.28.10.2418

16.

Vora

AC.

Saleem

TM.

Polomano

et al. Improved perioperative glycemic control by continuous insulin infusion under supervision of an endocrinologist does not increase costs in patients with diabetes. Endocr Pract. 2004;10(2):112-118.doi:10.4158/EP.10.2.112

17.

Halkos

ME.

Puskas

JD.

Lattouf

et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2008;136(3):631-640.doi:10.1016/j.jtcvs.2008.02.091

18.

D’Agostino

RS.

Jacobs

JP.

Badhwar

et al. The Society of thoracic surgeons adult cardiac surgery database: 2018 update on outcomes and quality. Ann Thorac Surg. 2018;105(1):15-23.doi:10.1016/j.athoracsur.2017.10.035

19.

Yount

KW.

Turrentine

FE.

Lau

CL.

Jones

. Putting the value framework to work in surgery. J Am Coll Surg. 2015;220(4):596-604.doi:10.1016/j.jamcollsurg.2014.12.037

20.

O'Brien

SM.

Shahian

DM.

Filardo

et al. The Society of thoracic surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg. 2009;88(1 Suppl):S23-S42.doi:10.1016/j.athoracsur.2009.05.056

21.

Van den Berghe

Wilmer

Hermans

et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-461.doi:10.1056/NEJMoa052521

22.

Vanhorebeek

Langouche

Van den Berghe

. Intensive insulin therapy in the intensive care unit: update on clinical impact and mechanisms of action. Endocr Pract. 2006;12 (Suppl 3):14-22.doi:10.4158/EP.12.S3.14

23.

Furnary

AP.

Gao

Grunkemeier

et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003;125(5):1007-1021.doi:10.1067/mtc.2003.181

24.

NICE-SUGAR Study Investigators Finfer

Chittock

et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-1297.doi:10.1056/NEJMoa0810625

25.

Umpierrez

Cardona

Pasquel

et al. Randomized controlled trial of intensive versus conservative glucose control in patients undergoing coronary artery bypass graft surgery: GLUCO-CABG trial. Diabetes Care. 2015;38(9):1665-1672.doi:10.2337/dc15-0303

26.

Cardona

Pasquel

FJ.

Fayfman

et al. Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy. J Diabetes Complications. 2017;31(4):742-747.doi:10.1016/j.jdiacomp.2017.01.003

27.

Lee

. Putting the value framework to work. N Engl J Med. 2010;363(26):2481-2483.doi:10.1056/NEJMp1013111

28.

Hawkins

RB.

Mehaffey

JH.

Narahari

et al. Improved outcomes and value in staged hybrid extent II thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2017;66(5):1357-1363.doi:10.1016/j.jvs.2017.03.420

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.01 MB

Electronic Glycemic Management System and Endocrinology Service Improve Value in Cardiac Surgery

Abstract

Background

Methods

Results

Conclusion

Keywords

Get full access to this article

References

Supplementary Material